Cilazapril

Cilazapril is an ACE-inhibitor prodrug used for hypertension and heart failure, hydrolysed to its active diacid metabolite cilazaprilat in vivo. Simson Pharma's Cilazapril reference standard and impurities support stability-indicating testing for this cardiovascular therapy.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cilazapril Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Cilazapril monohydrate
Cilazapril
Cilazapril EP Impurity A
Cilazapril EP impurity D
Cilazapril EP Impurity B
Cilazapril Impurity 1
Cilazapril EP Impurity C
N-Nitroso Cilazapril